169 Bibliographie générale
Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M et al. Amodiaquine- artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet. 2002; 359: 1365-1372.
Ajayi OI, Browne EN, Bateganya F, Yar D, Happi C, Falade CO et al. Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria:
A report from three study sites in sub-Saharan Africa. Malar J. 2008; 7:190.
Akulayi L, O’Connell. ACTWATCH, Evidence for malaria policy: Outlet Survey Report (Baseline). The Democratic Republic of the Congo, 08/201-11/2010.
http://www.actwatch.info/downloads/results/DRC%20Outlet%20Baseline,%20ACTwatch%2 012-09.pdf. Accès le 9 juin 2011.
Alker AP, Kazadi WM, Kutelemeni AK, Bloland PB, Tshefu AK, Meshnick SR. dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure inchildren with falciparum malaria in the Democratic Republic of Congo. Trop Med Int Health. 2008; 13(11):1384-91.
Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS et al. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J. 2007; 6:72 doi:10.1186/1475-2875-6-72.
Antonio-Nkondjio C, Ndo C, Kengne P, Mukwaya L, Awono-Ambene P, Fontenille D et al.
Population structure of the malaria vector Anopheles moucheti in the equatorial forest region of Africa. Malar J. 2008; 7: 120.
Asante KP, Owusu R, Dosoo D, Awini E, Adjei G, Etego SA et al. Adherence to Artesunate- Amodiaquine Therapy for UncomplicatedMalaria in Rural Ghana: A Randomised Trial of Supervised versus Unsupervised Drug Administration. J Trop Med. 2009; ID 529583: 7.
Ashley EA, McGready R, Proux S, Nosten F. Malaria. Travel Med Infect Dis. 2006; 4: 159- 173.
Baird JK. Resurgent malaria at the millennium. Control strategies in crisis. Drugs. 2000; 59 (4): 719-743.
170
Barat LM, Palmer N, Basu S, Worral E, Hanson K, Mills A. Do malaria control interventions reach the poor?: A view through the equity lens. Am J Trop Med Hyg. 2004; 71(2)S: 174- 178.
Beer N, Ali AS, Rotllant G, Abass AK, Omari RS, Al-mafazy AH et al. Adherence to artesunate–amodiaquine combination therapy for uncomplicated malaria in children in Zanzibar, Tanzania. Trop Med Int Health. 2009; 14(7): 766-774.
Bell DJ, Wootton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P et al. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J. 2009; 8:204.
Bloland P, Ettling M, Meek S. Combination therapy in Africa: hype or hope? Bull World Health Organ. 2000; 78 (12): 1378-1388.
Bloland P. A contrarian view of malaria therapy policy in Africa. Am J Trop Med Hyg. 2003;
68(2): 125-126.
Bloland P. Drug resistance in malaria. World Health Organization; 2001.
Bobossi Serengbe G, Ndoyo J, Longo JDD, Bezzo ME, Ouilibona SF, Ayivi B : Les aspects actuels du paludisme grave de l’enfant en milieu hospitalier pédiatrique centrafricain. Med Mal Infect. 2004; 34: 86-89.
Bonnet M, Broek I, van Herp M, Urrutia PP, van Overmeir C, Kyomuhendo J et al. Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies. Malar J. 2009; 8: 192.
Bourée P, Bisaro F, Couzigou C. Paludisme et grossesse. Revue francophone des laboratoires.
2008 ; 402 : 63-70.
Brabin BJ, Agbaje SO, Ahmed Y, Briggs ND () A birthweight nomogram for Africa, as a malaria-control indicator. Ann Trop Med Parasitol. 1999; 93(Suppl 1): S43-57. [Abstract].
171
Brabin BJ, Wasame M, Uddenfeldt-Wort U, Dellicour S, Hill J, Gies S. Monitoring and evaluation of malaria in pregnancy – developing a rational basis for control. Malar J. 2008;
7(Suppl 1):S6.
Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ. 1983;
61(6): 1005-1016.
Brasseur P, Agnamey P, Gaye O, Vaillant M, Taylor WRJ, Olliaro PL. Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal. Malar J. 2007; 6:150.
Breman JG, Alilio MS, Mils A. Conquering the intolerable burden of malaria: what’s new, what’s needed: a summary. Am. J. Trop. Med. Hyg. 2004 ; 71(2)S : 1-15.
Breslow NE, Day NE. Statistical Methods in Cancer Research; volume II: The Design and Analysis of Cohort Studies. (IARC Scientific publications N°82), Lyon: Internation Agency for Research on Cancer; 1987.
Briand V, Cottrell G, Massougbodji A, Cot M. Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar J. 2007; 6:160 doi:10.1186/1475-2875-6-160.
Brownson RC, Fielding JE, Maylhan C. Evidence-Based Public Health: A Fundamental Concept for Public Health Practice. Annu Rev Public Health. 2009; 30:175-201.
Brunet-Jailliy J. Le pendule du financement de la santé : De la gratuité au recouvrement des coûts. In : Kerouedan D. Santé internationale : les enjeux de santé au Sud. Paris : Presses de sciences Po ; 2011.
Camara B, Diack B, Diouf S, Signate/Sy H, Sall MG, Ba M et al. Les faibles poids de naissance: fréquence et facteurs de risque dans le district de Guédiawaye (Banlieue de Dakar – Sénégal). Médecine d’Afrique noire. 1996 ; 43 (5): 260-265.
Camara B, Diagne Gueye NR, Faye PM, Fall ML, Ndiaye JL, Ba M et al. Critères de gravité et facteurs pronostiques du paludisme chez l’enfant à Dakar. Med Mal Infect 2011 ; 41 : 63- 67.
172
Camara B, Diouf S, Diagne I, Fall A, Ba M, Sow D et al. Le paludisme grave de l’enfant en milieu hospitalier sénégalais. Med Mal Infect 2003 ; 33 : 45-48.
Carneiro I, Roca-Feltrer A, Griffin JT, Smith L, Tanner M, Schellenberg JA et al. Age- Patterns of Malaria Vary with Severity, Transmission Intensity and Seasonality in Sub- Saharan Africa: A Systematic Review and Pooled Analysis. PLoS One 2010; 5 (2): 1-10.
Chandiramani M, Tribe RM, Shennan AH. Preterm labour and prematurity. Obstetrics, gynecology and reproductive medicine. 2007; 17(8): 232-237.
Chiabi A, Takou V, Tchokoteu PF, Ngo Um S, Essoh L, Immuboeh P. Initial treatment of severe malaria in children is inadequate – a study from a referral hospital in Cameroon.
SAJCH 2009; 3 (1): 9-11.
Cholet E. La gratuité des soins : Une solution nationale pour la santé des plus pauvres ?. In : Kerouedan D. Santé internationale : les enjeux de santé au Sud. Paris : Presses de sciences Po ; 2011.
Coene J. Malaria in urban and rural Kinshasa: the entomological input. Med Vet Entomol.
1993; 7(2):127-37.
Comellini L, Tozzola A, Baldi F, Brusa S, Serra L, Agostoni C et al. Plasmodium vivax congenital malaria in a newborn of a Zairian immigrant. Ann Trop Paediatr. 1998; 18(1):41-3.
[Abstract].
Cot M. Maladies à transmission vectorielle en zone intertropicale: l’exemple du paludisme.
In : Astagneau, Ancelle T. Surveillance épidémiologique. Principes, méthodes et applications en santé publique. Paris : Lavoisier S.A.S ; 2011 : 272-276.
Cramer J. Practical Issues in Medication Compliance. Transplant Proc. 1999; 31 (4A): 7S–9S.
Crawley J, Hill J, Yartey J, Robalo M, Serufi lira A, Ba-Nguz A et al. From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.
Lancet Infect Dis. 2007; 7: 145-55.
173
Crawley j. Reducing the burden of anemia in infants and young children in malaria-endemic countries of Africa: from evidence to action. Am J Trop Med Hyg. 2004; 71(Suppl 2); 25-34.
D’Alessandro U, Langerock P, Bennett3 S, Francis N, Cham B, Greenwood B. The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia. Trans Royal Soc Trop Med Hyg. 1996; 9 (0):487-49.
D’Alessandro U. Commentary: Treating severe and complicated malaria. Br Med J 2004;
328: 155.
de Bernabé JV, Soriano T, Albaladejo R, Juarranz M, Calle ME, Matinez D et al. Risk factors for low birth weight: a review. Eur J Obstet Gynecol Reprod Biol. 2004; 116: 3-15.
De L. Costello AM, Singh M. Recent developments for neonatal health in developing countries. Semin Neonato1.1999; 4:131-139.
Delacollette C, Embonga B, Malengreau M. Response to chloroquine of infections with Plasmodium falciparum in the Kivu region of Zaïre. Preliminary observations. Ann Soc Belg Med Trop. 1983; 63(2):171-3.
Delacollette C, Van der Stuyft P, Molima K. Using community health workers for malaria control: experience in Zaire. Bull World Health Organ. 1996; 74(4):423-30.
Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S et al.
Adherence to the combination of sulphadoxine–pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health. 2004; 9(1): 62-67.
Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD.
Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007 ; 7: 93–104.
Djadou K, Sadzo-Hetsu K, Tatagan-Agbi K, Assimadi K, Sodzi K, Lapillonne A. Paramètres anthropométriques, fréquence et facteurs de risque du retard de croissance intra-utérin chez le nouveau-né à terme dans la région du Nord-Togo. Archd Pediatr. 2005; 12: 1320-1326.
Duffy P, Mutabingwa TK. Drugs combination for malaria: time to ACT? Lancet. 2004; 363:
3-4.
174
Elshibly EM, Schmalisch G. The effect of maternal anthropometric characteristics and social factors on gestational age and birth weight in Sudanese newborn infants. BMC Public Health.
2008; 8:244.
Enosse S, Magnussen P, Abacassamo F, Gómez- Olivé X, Rønn AM, Thompson Ret al.
Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique. Malar J. 2008; 7:115.
Eriksen J, Nsimba SE, Minzi OMS, Sanga AJ, Petzold M, Gustafson LL et al. Adoption of the new antimalarial drug policy in Tanzania – a cross-sectional study in the community. Trop Med Int Health. 2005; 10(10): 1038-1046.
Eriksen J, Tomson G, Mujinja P, Warsame MY, Jahn A, Gustafsson LL. Assessing health worker performance in malaria case management of underfives at health facilities in a rural Tanzanian district. Trop Med Int Health. 2007, 12(1) : 52-61.
Er-Rami M, Lemkhennete Z, Mosnier E, Abouzahir A. Evaluation de l’importance du paludisme chez les militaires de l’ONU déployés sur le district d’Ituri en ex-Zaïre pendant une période 12 mois des années 2005-2006. Med Trop. 2011 ; 71 (1): 37-40.
Eymard C. Des modèles de l’éducation et de la santé à l’activité d’éducation thérapeutique.
In : Foucaud J, Bury JA, Balcou-Debussche M,Eymard C, dir. Education thérapeutique du patient. Modèles, pratiques et évaluation. Saint-Denis : Inpes, coll. Santé en action ; 2010 : 412.
Faye B, Ndiaye JL, Ndiaye D, Dieng Y, Faye O, Gaye O. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Malar J. 2007; 6:80.
Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence. The Concordance of Self-Report With Other Measures of Medication Adherence A Summary of the Literature. Med Care.
2004; 42(7) : 649 - 652.
Garcia LS. Malaria Update for the Clinical Microbiology Laboratory: a New Species, Plasmodium knowlesi, and New Diagnostic Tests. Clinical Microbiology Newsletter 2010;
175 32(17): 127-133.
Garin B, Salun JJ, Peyron F, Vigier JP, Busangu I, Perrone J. Rapid in vivo detection of chloroquine resistance by the Quantitative Buffy Coat Malaria Diagnosis System. Am J Trop Med Hyg. 1992; 47(4):446-9.
Gething PW, Kirui VC, Alegana VA, Okiro EA, Noor AM, Snow RW. Estimating the Number of Paediatric Fevers Associated with Malaria Infection Presenting to Africa’s Public Health Sector in 2007. PLoS Med. 2010 ; 7 (7) e1000301 : 1-12.
Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth.
The Lancet. 2008; 371: 75-84.
Gomes M, Wayling S, Pang L. Interventions to improve the use of antimalarials in South-East Asia: an overview. Bull World Health Organ. 1998; 76 (1): 9-19.
Green L., Kreuter M. Health Program Planning. An educational and ecological approach. 4th edition. New-York: Mc Graw Hill ; 2005.
Greenberg AE, Ntumbanzondo M, Ntula N, Mawa L, Howell J, Davachi F. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull World Health Organ. 1989; 67(2):189-96.
Greenwood B. Review. Intermittent preventive treatment - a new approach to the prevention of malaria in children in areas with seasonal malaria transmission. Trop Med Int Health. 2006;
11(7): 983-91.
Greenwood BM, Bojang K, Whitty CM, Target GAT. Malaria. Lancet. 2005; 365: 1487-98.
Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH et al. The International Limits and Population at Risk of Plasmodium vivax Transmission in 2009. PLoS Negl Trop Dis. 2010; 4(8): e774.
Guyatt HL, Snow RW. Malaria in pregnancy as an indirect cause of infant mortality in sub- Saharan Africa. Trans R Soc Trop Med Hyg. 2001; 95: 569-576.
176
Hawkes M, Katsuva JP, Masumbuko CK. Use and limitations of malaria rapid diagnostic testing by community health workers in war-torn Democratic Republic of Congo. Malar J 2009; 8:308.
Hosmer DW, Lesmeshow S. Applied logistic regression. Second edition. New York : Wiley- Interscience Publication ; 2000.
Imbert P. Paludisme de l’enfant: critère de gravité. Archives de pédiatrie 2003 ; 10 (5) : 532s- 538s.
International Artemisinin Study Group: Artesunate combinations for treatment of malaria:
meta-analysis. Lancet. 2004; 363: 9-17.
Jeske J, Bergiel A, Kamerys, Malinowska B, Malowiejska M. Selected parasitic and infectious diseases in persons returning from the tropics. (Article en polonais). Wiad Parazytol. 1999; 45 (2):119-24. [Abstract].
Kabeya K, Faurant C, Tshibemba M, Kankolongo L, Krim G. Appréciation d'une association chloroquine-spiramycine dans le traitement du paludisme en zone de chloroquino-résistance modérée. Bull Soc Pathol Exot. 1990; 83(2):206-10.
Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, Bloland P. Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am J Trop Med Hyg. 2004; 71(6): 715-722.
Kalanda GC, Hill J, Verhoeff FH, Brabin BJ: Comparative efficacy of chloroquine and sulphadoxine-pyrimethamine in pregnant women and children: a meta-analysis. Trop Med Int Health. 2006; 11(5):569-577
Karch S, Asidi N, Manzambi ZM, Salaun JJ. La faune anophélienne et la transmission du paludisme humain à Kinshasa (Zaïre). Bull Soc Pathol Exot. 1992;85(4):304-9.
Karch S, Mouchet J. Anopheles paludis. Vecteur important du paludisme au Zaïre. Bull Soc Pathol Exot. 1992; 85(5):388-9.
177
Kayembe PK. Impact du passage à l’échelle des activités de lutte contre le VIH, la tuberculose et le paludisme dans le cadre spécial du Fonds Mondial. Rapport de l’évaluation de l’impact. République démocratique du Congo. Macro International Inc. Consulté le 25
juillet 2011.
http://rochr.qrc.com/bitstream/123456789/962/1/5YEGF%20Final%20Report%20DRC%201 0-01-19.pdf
Kazadi WM, Vong S, Makina BN, Mansthumba JC, Kabuya W, Kebela BI et al. Assessing the efficacy of chloroquine and sulfadoxine pyrimethamine for the traitement of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo. Trop Med Int Health. 2003; 8(10): 868-875.
Kramer MS: The Epidemiology of Adverse Pregnancy Outcomes: An Overview. The J Nutr.
2003; (1592s): 1592-1596.
Lagerberg RE (2008) Malaria in Pregnancy: A Literature Review. J Midwifery Womens Health, 53(3): 209-15.
Lehmann T, Licht M, Elissa N, Maega BT, Chimumbwa JM, Watsenga FT et al. Population Structure of Anopheles gambiae in Africa. J Hered. 2003; 94(2):133-47.
Lejeune C. Précarité et prématurité. Journal de pédiatrie et de puériculture. 2008 ; 696 (article in press).
Lindsay A. Thompson, David C. Goodman, Chiang-Hua Chang et al. Regional Variation in Rates of Low Birth Weight. Pediatrics. 2005; 116: 1114-1121.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet.
2006; 367: 1747–57.
Lukuka KA, Fumie OS, Mulumbu MR, Lokombe BJ, Muyembe TJJ. Prévalence du paludisme à l’accouchement dans quatre maternités de la ville de Kinshasa, République Démocratique du Congo. Bull Soc Pathol Exot. 2006; 99(3): 200-1.
178
Lusakibanza M, Mesia G, Tona G, Karemere S, Lukuka A, Tits M et al. In vitro and in vivo antimalarial and cytotoxic activity of five plants used in congolese traditional medicine. J Ethnopharmacol. 2010; 129(3):398-402.
Manirakiza A, Njuimo SP, Le Faou A, Malvy D, Millet P. Availability of Antimalarial Drugs and Evaluation of the Attitude and Practices for the treatment of uncomplicated Malaria in Bangui, Central African Republic. J Trop Med. 2010; ID 510834: 5.
Mannan AA, Malik EM, Ali KM. Antimalarial prescribing and dispensing practices in health centres of Khartoum state, 2003–04. East Mediterr Health J. 2009; 15 (1): 122-128.
Marks F, Evans J, Meyer CG, Browne EN, Flessner C, von Kalckreuth V et al. High Prevalence of Markers for Sulfadoxine and Pyrimethamine Resistance in Plasmodium falciparum in the Absence of Drug Pressure in the Ashanti Region of Ghana. Antimicrob Agents Chemother. 2005; 49(3):1101-1105.
Marks F, von Kalckreuth V, Kobbe R, Adjei S, Adjei O, Horstmann RD et al. Parasitological Rebound Effect and Emergence of Pyrimethamine Resistance in Plasmodium falciparum after Single-Dose Sulfadoxine- Pyrimethamine. J Infect Dis. 2005; 192:1962-5.
Marsh K., Forster D., Waruiru C. Mwangi I, Winstanley M, Marsh V et al. Indicators of life- threatening malaria in African children. N Eng J Med. 1995; 332 (21): 1399-1404.
Martini J. Paludisme: progrès mitigés et nouveaux espoirs. In : Kerouedan D. Santé internationale : les enjeux de santé au Sud. Paris : Presses de sciences Po, 2011.
Mashako M, Kingway MP, Kayembe N. Traitement par le chlorhydrate d’halofantrine du paludisme à plasmodium falciparum dans une zone de résistance. Analyse de 54 cas pédiatriques. Ann Soc Belg Med Trop. 1990;70(1):25-32.
Mbanzulu PN, Kadima N, Ngimbi NP, Ngangoue C, Elenga E, Kaba S et al. Chimio- résistance de Plasmodium falciparum à Kinshasa. Tests in vivo et absorption de chloroquine.
Bull Soc Pathol Exot Filiales. 1988; 81(1):83-7.
179
Mbaye A, Richardson K, Balajo B, Dunyo S, Shulman C, Milligan P et al. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine–
pyrimethamine in Gambian multigravidae. Trop Med Int Health. 2006; 11(7): 992-1002.
McCombie SC. Treatment seeking for malaria_ a review of recent research. Soc. Sci. Med.
1996; 43(6): 933-945.
McCormick MC (1985) The contribution of low birth weight to infant mortality and childhood morbidity. New England Journal of Medicine, 312: 82–90 [Abstract].
Médecins Sans Frontières. Prescription complète : Un meilleur traitement contre le paludisme pour plus de patients, l’expérience de MSF. MSF, Centre Opérationnel de Bruxelles, 2008.
Menedez C, D’Alessandro U, ter Kuile OF. Reducing the burden of malaria in pregnancy by preventives strategies. Lancet Infect Dis. 2007; 7: 126–35.
Menendez C, Bardajı A, Sigauque B, Romagosa C, SanzS, Serra-Casas E et al. A Randomized Placebo-Controlled Trial of Intermittent Preventive Treatment in Pregnant Women in the Context of Insecticide Treated Nets Delivered through the Antenatal Clinic.
PLos One; 2008 3(4): e1934. doi:10.1371/journal.pone.0001934.
Menendez C, Romagosa C, Ismail MR, Carrilho C, Saute F, Osman N et al. An Autopsy Study of Maternal Mortality in Mozambique: The Contribution of Infectious Diseases. PLoS Med. 2008; 5(2): e44. doi:10.1371/ journal.pmed.0050044
Meremikwu M, Okomo U, Nwachukwu C, Oyo-Ita A, Eke-Njoku J, Okebe J et al.
Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study. Malar J. 2007; 6: 55.
Meshnick SR, Alker AP: Amodiaquine and combination chemotherapy for malaria. Am J Trop Med Hyg. 2005; 73(5): 821-823.
Mesia GK, Tona GL, Penge O, Lusakibanza M, Nanga TM, Cimanga RK et al. Antimalarial activities and toxicities of three plants used as traditional remedies for malaria in the Democratic Republic of Congo: Croton mubango , Nauclea pobeguinii and Pyrenacantha staudtii. Ann Trop Med Parasitol. 2005; 99(4):345-57.
180
Mesia K, Cimanga K, Tona L, Mampunza MM, Ntamabyaliro N, Muanda T et al. Assessment of the short-term safety and tolerability of a quantified 80 % ethanol extract from the stem bark of Nauclea pobeguinii (PR 259 CT1) in healthy volunteers: a clinical phase I study.
Planta Med. 2010; 77(2):111-6.
Mesia K, Cimanga RK, Dhooghe L, Cos P, Apers S, Totté J et al. Antimalarial activity and toxicity evaluation of a quantified Nauclea pobeguinii extract. J Ethnopharmacol.
2010;131(1):10-6.
Messina JP, Taylor SM, Meshnick SR, Linke MA, Tshefu AK, Atua B et al. Population, behavioral and environmental drivers of malaria prevalence in the Democratic Republic of Congo. Malar J. 2011; 10:161. doi:10.1186/1475-2875-10-161.
Meuris S, Piko BB, Eerens P, Vanbelinghen, Dramaix M, Hennart P. Gestational malaria:
assessment of its consequences on fetal growth. Am J Trop Med Hyg. 1993; 48(5): 603-609.
Meuris S, Piko BB, Eerens P, Vanbellinghen AM, Dramaix M, Hennart P. Gestational malaria: assessment of its consequences on fetal growth. Am J Trop Med Hyg. 1993; 48(5):
603-9.
Ministère de la Santé Publique. Déclaration de politique nationale de lutte contre le paludisme. Kinshasa ; 2007.
Ministère de la santé. Normes sanitaires de la zone de santé. Kinshasa ; 2002.
Ministère du plan, Unicef. Enquête nationale sur la situation des enfants et des femmes MICS/2001. Rapport d’analyse. Kinshasa ; 2002.
Ministère du plan, Macro International INC. Enquête Démographique et de Santé (ES-RDC) 2007. Calverton : Maryland, USA ; 2008.
Ministère du plan, Unicef. Enquête par grappes à indicateurs multiples. MICS RDC 2010.
Résultats préliminaires. Kinshasa ; 2010.
Mita T, Kaneko A, Lum Jk, Bwijo B, Takechi M, Zungu IL et al. Recovery of chloroquine sensitivity and low prevalence of the plasmodium falciparum chloroquine resistance
181
transporter gene mutation K76t following the discontinuance of chloroquine use in Malawi.
Am J Trop Med Hyg. 2003; 68(4): 413-415.
Mobula L, Lilley B, Tshefu AK, Rosenthal PJ. Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo. Am J Trop Med Hyg. 2009; 80(4): 555-8.
Mouchet J, Carnevale P, Coosemans M, Fontenil D, Ravaonjanahary C, Richard A et al.
Typologie du paludisme en Afrique. Cahiers Santé 1993 ; 3 : 220-38.
Moyen G, Mbika Cardorelle A, Kambourou J, Oko A, Mouko A, Obengui. Paludisme grave de l’enfant à Brazzaville. Médecine d’Afrique Noire 2010 ; 57(2) : 113-116.
Mugisho E, Dramaix M, Porignon D, Mouafo JB, Vanbellinghen AM, Hennart Pet al.
Ineffectiveness of chloroquine antenatal prophylaxis in East of Democratic Republic of Congo (RDC) . Trop Doct. 2003; 33(3):177-8.
Mugisho E. Effets comparés de la prophylaxie par la chloroquine ou la sulfadoxine- pyrimethamine, données lors des visites prénatales au Nord-Kivu en République Démocratique du Congo, sur la santé du couple mère-enfant et la croissance du nouveau-né.
in Contribution à la santé du couple mère-enfant dans la région du Nord-Kivu (RDC) : de l’intérêt de la consultation prénatale ? Thèse présentée en vue de l’obtention du titre de docteur en sciences de la santé publique. Bruxelles : Université Libre de Bruxelles ; 2002, unpub.
Mukadi P, Gillet P, Lukuka A, At;ua B, Kahodi S, Lokombe J et al. External quality assessment of malaria microscopy in the Democratic Republic of the Congo. Malar J 2011;
10:308.
Mulumba PM, Kabongo MJ, Woto EE. La prévention de l’hypotrophie fœtale échappe désormais à la chloroquino-prophylaxie dans l’environnement de Kinshasa. Med Trop. 2003;
63(2):168-70.
Murphy DJ. Epidemiology and environnemental factors in preterm labor. Best Pract Res Clin Obstet Gynaecol. 2007; 21 (5): 773-789.
182
Mutabingwa KT, Bolla CM., Li J-L, Domingo JG, Li X, Fried M et al. Maternal Malaria and Gravidity Interact to Modify Infant Susceptibility to Malaria. PLoS Med. 2005; (2)12, e407:
1260-1268.
Mutabingwa TK. Artemisin-based conmbination therapies (ACTs): best hope for malaria but inaccessible for needy! Acta Trop. 2005; 95: 305 -315.
Newman RD, Parise ME., Slutsker L, Nahlen B, Steketee RW. Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med Int Health. 2003; (8)6: 488-506.
Ngimbi NP, Wery M, Henry MC, Mulumba MP. Réponse in vivo à la chloroquine au cours du traitement du paludisme à Plasmodium falciparum en région suburbaine de Kinshasa, Zaïre. Ann Soc Belg Med Trop. 1985;65 Suppl 2:123-35.
Nguyen-Dinh P, Greenberg AE, Kabote N, Davichi F, Goussard B, Embonga B. Plasmodium falciparum in Kinshasa, Zaire: in vitro drug susceptibility studies. Am J Trop Med Hyg. 1987;
37(2):217-9.
Nguyen-Dinh P, Schwartz IK, Sexton JD, Egumb B, Bolange B, Ruti K et al. In vivo and in vitro susceptibility to chloroquine of Plasmodium falciparum in Kinshasa and Mbuji-Mayi, Zaire. Bull World Health Organ. 1985; 63(2):325-30.
Nosten F, van Vugt M, Price R, Luxemburger C, Thway K L, Brockman A et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 2000; 356: 297–302.
Nyirjesy P, Kavasya T, Axelrod P, Fischer PR. Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine chemoprophylaxis. Clin Infect Dis. 1993; 16 (1):127-32.
Nzayirambaho M, Freund RJ, Millet P, Lombrail P, Malvy D., Potel G. Evaluation de l’application du protocole national de traitement du paludisme simple dans les formations sanitaires de la ville de Kigali, Rwanda. Med Mal infect. 2008; 38: 119-124
183
Obonyo BO, Juma EA, Ogutu BR, Vulule JM, Lau J. Amodiaquine combined with Sulfadoxine6Pyrimethamine versus artemisin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis. Trans Roy Soc Trop Med Hyg.
2007; 101: 117-126.
Odio W. Rapport de la revue de résultats des études de l’évaluation de l’efficacité thérapeutique des antipaludiques en République Démocratique du Congo de mars 1996 a juin 2004. Kinshasa : Programme National de lutte contre le paludisme ; 2005.
Ogbonna A, Uneke CJ. Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000. Trans R Soc Trop Med Hyg. 2008; 102: 621-627.
Okiro EA, Al-Taiar, Reyburn H, Idro R, Berkley JA, Snow R. Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity.
Malar J 2009, 8:4 doi:10.1186/1475-2875-8-4.
Olliaro P: Mode of action and mechanisms of resistance for antimalarial drugs. Pharmacol Ther. 2001; 89: 207- 219.
Olson R, Verley J, Santos L, Salas C. What We Teach Students About the Hawthorne Studies: A Review of Content Within a Sample of Introductory I-O and OB Textbooks. The Industrial-Organizational Psychologist. 2004; 41(3): 23-39.
Onyamboko MA, Meshnick SR, Fleckenstein L, Koch MA, Atibu J, Lokomba V et al.
Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC. Malar J. 2011; 10:49.
Organisation Mondiale de la Santé. Prise en charge de l’enfant atteint d’infection grave ou de la malnutrition sévère. Directives des soins pour les centres de transfert de premier niveau dans les pays en développement. Genève : OMS ; 2002.
Organisation Mondiale de la Santé. Rapport sur la santé dans le monde 2005 : donnons sa chance à chaque mère et chaque enfant. Genève : OMS ; 2005 : 48.
184
Organisation Mondiale de la Santé. "Le sommet d’Abuja sur le projet Faire Reculer le Paludisme", Secrétariat du partenariat Faire Reculer le Paludisme. Genève : OMS ; 2003.
Organisation Mondiale de la Santé. "Plan stratégique mondial Faire Reculer le Paludisme 2005-2015". Genève : Secrétariat du partenariat Faire Reculer le Paludisme, OMS ; 2005.
Organisation Mondiale de la Santé. Actualisation des objectifs, cibles, jalons et priorités du Plan d'action mondial contre le paludisme (GMAP) au-delà de 2011. Consulté le 27 juin 2011, http://www.rollbackmalaria.org/gmap/gmap2011update-fr.pdf.
Organisation Mondiale de la Santé. L’utilisation des antipaludiques. Rapport d’une consultation informelle de l’OMS. Genève : OMS ; 2001.
Organisation Mondiale de la Santé. Les combinaisons thérapeutiques antipaludiques. Rapport d’une consultation technique de l’OMS. Genève : OMS ; 2001.
Organisation Mondiale de la Santé. Mise à l’échelle nationale de la prise en charge à domicile du paludisme. De la recherche à la mise en œuvre. Genève : OMS ; 2005.
Orton L, Barnish G. Unit-dose packaged drugs for treating malaria (Review). Cochrane Database Syst Rev. 2005; Issue 2. Art. No.:CD004614. DOI:
10.1002/14651858.CD004614.pub2.
Paluku KM, Breman JG, Moore M, Ngimbi NP, Sexton JD, Roy J et al. Response of children with Plasmodium falciparum to chloroquine and development of a national malaria treatment policy in Zaire. Trans R Soc Trop Med Hyg. 1988; 82(3):353-7.
Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg. 1998, 59:813-822.
Pasvol G: The treatment of complicated and severe malaria. Br Med Bull 2005; 75 and 76:
29-47.
185
Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E et al. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
Lancet. 2005; 365: 1467-73.
Price RN, Nosten F, Luxemburger C, van Vugt M, Phaipun L, Chongsuphajaisiddhi Tet al.
Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans Roy Soc Trop Med Hyg. 1997; 91: 574-577.
Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Application to addictive behaviors. Am psycho. 1992; 47(9): 1102 - 1114.
Prochaska JO, Norcross JC, DiClemente CC. Changing for good. Avon Books. 3rd edition;
1995.
Programme National de Lutte contre le Paludisme. " Faire Reculer le Paludisme ". Plan stratégique 2002 – 206. Kinshasa: PNLP; 2002.
Programme national de lutte contre le paludisme, " Faire Reculer le Paludisme". Plan stratégique 2007-2011. Kinshasa : PNLP ; 2007.
Programme national de lutte contre le paludisme, “Faire reculer le paludisme, Plan stratégique 2009 - 2013”, PNLP, Ministère de la santé, RDC, 2009.
Programme national de lutte contre le paludisme, Déclaration de politique nationale de lutte contre le paludisme. Kinshasa : PNLP, Ministère de la santé, RDC ; 2009.
Programme national de lutte contre le paludisme, Guide technique de formation en prévention et prise en charge du paludisme. (Niveau hôpital général de référence). Kinshasa : PNLP, Ministère de la santé, RDC ; 2009.
Programme national de lutte contre le paludisme, Guide technique de formation en prévention et prise en charge du paludisme. (Niveau centre de santé). Kinshasa : PNLP, Ministère de la santé, RDC ; 2009.
Programme national de lutte contre le paludisme. Cartographie des interventions du PNLP en
186
RDC en 2010 et 2011. Kinshasa : PNLP, Ministère de la santé; 2010.
Programme national de lutte contre le paludisme. Rapport annuel 2009. Kinshasa : 2009.
Programme national de lutte contre le paludisme. Rapport annuel 2010. Kinshasa : 2011.
Rahmana MdM, Dondorpa AM, Daya NPJ, Lindegardha N, Imwonga M, Faiz MA et al.
Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Trans Roy Soc Trop Medc Hyg. 2008; 102: 861- 867.
Raobijaona H, Randrianotahina CH, Razanamparany M. Le paludisme grave de l’enfant observé au Service de Pédiatrie du Centre Hospitalier de Befelatanana à Antananarivo (Madagascar) en 1996-1998. Arch Inst Pasteur Madagascar 2000; 66 (1&2) : 23-25.
Robinson JN, Regan JA, Norwitz ER. The epidemiology of preterm labor. Semin Perinatol.
2001; 25(4): 204-214.
Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mbango C, Molineux ME. Intermittent Sulfadoxine-pyrimethamine in pregnancy : effectivness against malaria in Blantyre, Malawi, in 1997-99. Trans R Soc Trop Med Hyg. 2000; 94 (5): 549-53.
Rogerson SJ, Hviid L, Duffy PE, Leke RFG, Taylor DW. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis. 2007; 7: 105–17.
Roll Back Malaria. Plan d’action mondial contre le paludisme. Genève : OMS ; 2008.
Rowe AK, Hamel MJ, Fanders WD, Doutizanga R, Deming MS. Predictors of correct treatment of children with fever seen as outpatient health facilities in the Central African Republic. Am J Epidemiol. 2000; 151:1029-1035.
Rowe AK, Ponce de Léon GF, Mihigo J, Carolina A, Sentelli FS, Miller NP et al. Quality of malaria case management at outpatient health facilities in Angola. Malar J. 2009; 8: 275.
187
Schultz LJ, Steketee RW, Chitsulo L, Macheso A, Kazembe P, Wirima JJ. Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalrial regimens for use in pregnancy: chloroquine and sulfadoxine-pyrimethamine. Am J Trop Med Hyg. 1996;
55(1): 87-94.
Sibley CH, Hyde JE, Sims PFG, Plowe CV, Kublin JG, Mberu EK et al. Pyrimethamine–
sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 2001; 17(12) : 582-588.
Sirima BS, Cotte HA, Konaté A, Moran CA, Asamoa K, Bougouma CE et al. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupéla district, Burkina Faso. Am J Trop Med Hyg. 2006; 75(2): 205-211.
Slaterry MM, Morrisson JJ. Preterm delivery. The Lancet. 2002; 360: 1489-1497.
Souares A, Lalou R, Sene I, Sow D, Le Hesran JY. Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal. Trans R Soc Trop Med Hyg. 2008; 102: 751-758.
Souares A, Moulin P, Sarrassat S, Carlotti MP, Lalou R, Le Hesran JY. Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal. Malar J. 2009; 8:257.
Steketee RW. Pregnancy, Nutrition and Parasitic Diseases. J Nutr. 2003 ; supl: 1661-1667.
Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am. J. Trop. Med. Hyg. 2001; 64(1, 2)S : 28–35
Swarthout TD, Counihan H, Senga RKK, van den Breok I. Paracheck-Pf® accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis?. Malar J 2007; 6:58.
Swarthout TD, van den Broek IV, Kayembe G, Montgomery J, Pota H, Roper C.
Artesunate + amodiaquine and artesunate + sulphadoxine–pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination
188
of sulphadoxine and pyrimethamine-resistant haplotypes. Trop Med Int Health. 2006; 11(10):
1503-1511.
Tako EA, Zhou A, Lohoue J, Leke R, Taylor DW, Leke RFG. Risk factors for placental malaria and its effects on pregnancy outcome in Yaounde, Cameroon. Am J Trop Med Hyg.
2005; 72(3): 236-242.
Taylor SM, Messina JP, Hand CC, Juliano JJ, Muwonga J, Tshefu AK et al. Molecular malaria epidemiology: mapping and burden estimates for the Democratic Republic of the Congo, 2007. PLoS ONE. 2011 ; 6(1): e16420. doi:10.1371/journal.pone.0016420.
ter Kuile FO, van Eijk A M, Filler SJ. Effect of the sulfadoxine-pyrimethamine resistance on the Efficacy of Intermittent Preventive Therapy for Malaria Control During Pregnancy. A Systematic Review. JAMA. 2007; 297(23): 2603-2616
ter Kuile OF, Terlouw DJ, Phillips-Howard PA, Hawley WA, Friedman JF, Kariuki SK et al.
Reduction of malaria during pregnancy by permethrin-treated bed nets in an area of intense perennial malaria transmission in Western Kenya. Am J Trop Med Hyg. 2003; 68(Suppl 4):
50-60.
The East African Network for Monitoring Antimalarial Treatment (EANMAT): The efficacy of antimalarial monotherapies, sulphadoxine– pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop Med Int Health. 2003; 8 (10): 860-867.
The Globalfund To fight AIDS, Tuberculosis and Malaria. Agreements reduce prices of malaria medicines by up to 80 %, Global Fund and drug manufacturers cooperate to end deaths from malaria. Press release, Geneva, 14 July 2010.
http://www.theglobalfund.org/en/mediacenter/pressreleases/Agreements_reduce_prices_of_m alaria_medicines_by_up_to_80__/ Accès, le 25 octobre 2011.
Tona L, Cimanga RK, Mesia K, Musuamba CT, De Bruyne T, Apers S et al. In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. J Ethnopharmacol. 2004; 93(1):27-32.
Tona L, Mesia K, Ngimbi NP, Chrimwami B, Okond'ahoka, Cimanga K et al. In-vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllanthus niruri. Ann
189 Trop Med Parasitol. 2001; 95(1):47-57.
Tona L, Ngimbi NP, Tsakala M, Mesia K, Cimanga K, Apers S et al. Antimalarial activity of 20 crude extracts from nine African medicinal plants used in Kinshasa, Congo. J Ethnopharmacol. 1999; 68(1-3):193-203.
Trape JF, Pison G, Preziosi MP, Enel C, du Loû AD, Delaunay V, et al. Impact of chloroquine resistance on malaria morbidity. Comptes Rendus Acad Sci Paris. sciences de la vie, 1998; 321: 689–697.
Trape JF, Pison G, Spiegel A, Enel C, Rogier C. Combating malaria in Africa. Trends Parasitol. 2002; 18(5): 224-230.
Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg.
2001; 64(1,2)S: 12-17.
Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS et al. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether- lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomized non-inferiority trial. Lancet. 2010; 375(9724):1457-67.
UNICEF/WHO. Antenatal care in developing countries: promises, achievements and missed opportunities: an analysis of trends, levels and differentials, 1990-2001. World Health Organization; 2003.
Vahdaninia M, Tavafian SS, Montazeri A. Correlates of low birth weight in term pregnancies:
a retrospective study from Iran. BMC Pregnancy Childbirth. 2008; 8:12.
Vallely A, Vallely L, Changalucha J, Greenwood B, Chandramohan D: Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed? Malar J.
2007; 6:16 (http://www.malariajournal.com/content/6/1/16).
Van Geertruyden JP, Thomas F, Erhart A, D’alessandro U: The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg. 2004; 71(Suppl 2): 35-40.
Wasunna B, Zurovac D, Goodman CA, Snow RW. Why don't health workers prescribe ACT?
A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar J.
190 2008; 7:29.
White N. Antimalarial drug resistance and combination chemotherapy. Phil Trans R Soc B.
1999; 354: 739-749.
White NJ. Intermittent Presumptive Treatment for Malaria. PLoS Med. 2005; 2(1):e3, DOI:
10.1371/journal.pmed.0020003.
White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW et al. Averting a malaria disaster. Lancet. 1999 ; 353: 1965-1967.
Williams HA, Durrheim D, Shretta R. The process of changing national malaria treatment policy: lessons from country-level studies. Health Policy Plan. 2004; 19(6): 356-370.
Williams HA, Durrheim D, Shretta R. The process of changing national malaria treatment policy: lessons from country-level studies. Health Policy Plan. 2004; 19(6): 356-370.
Wilson PE, Kazadi W, Kamwendo DD, Mwapasa Mwapasa, Purfield A, Meshnick SR.
Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay. Acta Trop. 2005; 93(1):97-106.
Wolday D, Kibreab T, Bukenya D, Kodes R. Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire.
Trans R Soc Trop Med Hyg. 1995; 89(6):654-6.
World Health Organization, Secretariat to the RBM Partnership. Implementation of New Antimalarial Treatment Policies in Africa. Discussion Paper for the RBM PARTNERS’
MEETING 26-28 February 2002. Geneva: WHO; 2002.
World Health Organization, UNICEF. Antenatal care in developing countries: promises, achievements and missed opportunities: an analysis of trends, levels and differentials, 1990- 2001. Geneva, WHO; 2003.
World Health Organization. Guidelines for the treatment of malaria-2nd edition. Geneva, WHO ; 2010.
World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000;
191 94(Suppl 1): 1-99.
World Health Organization. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville: World Health Organization, Regional office for Africa; 2004.
World Health Organization. The world health report 2005, Make every mother and child count. WHO, Geneva; 2005: 68.
World Health Organization. Recommendations on the use of Sulfadoxine-Pirymethamine (SP) for Intermittent Preventive Treatment during pregnancy (IPT) in areas of moderate to high resistance to SP in Africa Region. Brazzaville : WHO, Regional office for Africa; 2005.
Available from: http//:afro.who.int/malaria/publications/who_sp_ statment.pdf. Accessed on October 17th 2008.
World Health Organization. Technical Expert Group meeting on intermittent preventive treatment in pregnancy (IPTp). WHO headquarter, Geneva; 2008.
World Health Organization, UNICEF. The Africa Malaria Report 2003. Geneva:
WHO/UNICEF; 2003.
World Health Organization. The Africa Malaria Report 2006. WHO, Regional offices for Africa and Eastern Mediteranean; 2006.
World Health Organization. World Malaria Report 2008. WHO, Genève; 2008.
World Health Organization. World Malaria Report 2009. WHO, Genève, 2009.
World Health Organization. World Malaria Report 2010. Genève: WHO; 2010.
World Health Organization. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Geneva: WHO;1996.
World Health Organization. Assessment and monitoring of antimalaria drugs efficacy for the treatment of uncomplicated falciparum malaria. Geneva: WHO; 2003.
World Health Organization. Guidelines for the treatment of malaria. Geneva: WHO; 2006.
192
World Health Organization. Guidelines for the treatment of malaria, 2nd edition. WHO, Geneva, 2010.
World Health Organization. Recommendations on the use of Sulfadoxine-Pirymethamine (SP) for Intermittent Preventive Treatment during pregnancy (IPT) in areas of moderate to high resistance to SP in Africa Region. WHO, Regional office for Africa. Available from:
http//:afro.who.int/malaria/publications/who_sp_statment.pdf. Accessibilité vérifiée le 17 octobre 2008.
World Health Organization. Susceptibility of Plasmodium falciparum to antimalarial drugs.
Monitoring Antimalarial Drug Resistance, Report on global monitoring 1996-2004. Genève:
WHO; 2005.
World Health Organization. The use of antimalarial drugs, report of a WHO informal consultation. Genève: WHO; 2000.
Yekutiel P. Lessons from the big eradication campaigns. World health forum. 1981; (4)S:
465-490.
Yeung S, White NJ. How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health. 2005; 10 (2): 121-138.
Zurovac D, Ndhlovu M, Rowe AK, Hamer DH, Thea DM, Snow R. Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study. Br Med J. 2005; 331: 734.
Zurovac D, Ndhlovu M, Rowe AK, Hamer DH, Thea DM, Snow R: Paediatric malaria case- management artemether-lumefantrine in Zambia: a repeat cross sectional study. Malar J.
2007; 6: 31.
Zurovac D, Rowe AJ, Ochola SA, Noor AM, Midia B, English M et al. Predictors of the quality of health worker treatment practices for uncomplicated malaria in Government health facilities in Kenya. Int J Epidemiol. 2004; 33:1080-1091.
